Kestra Advisory Services’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $285K | Sell |
960
-170
| -15% | -$55K | ﹤0.01% | 2678 |
|
|
2025
Q4 | $343K | Sell |
1,130
-45
| -4% | -$14.7K | ﹤0.01% | 2434 |
|
|
2025
Q3 | $400K | Sell |
1,175
-211
| -15% | -$64.1K | ﹤0.01% | 2214 |
|
|
2025
Q2 | $336K | Buy |
1,386
+27
| +2% | +$6.62K | ﹤0.01% | 2266 |
|
|
2025
Q1 | $370K | Sell |
1,359
-244
| -15% | -$57K | ﹤0.01% | 2024 |
|
|
2024
Q4 | $296K | Buy |
1,603
+169
| +12% | +$34.5K | ﹤0.01% | 2227 |
|
|
2024
Q3 | $322K | Sell |
1,434
-121
| -8% | -$21.8K | ﹤0.01% | 2045 |
|
|
2024
Q2 | $222K | Sell |
1,555
-16
| -1% | -$2.47K | ﹤0.01% | 2330 |
|
|
2024
Q1 | $246K | Buy |
1,571
+110
| +8% | +$17.7K | ﹤0.01% | 2139 |
|
|
2023
Q4 | $264K | Sell |
1,461
-2
| -0.1% | -$362 | ﹤0.01% | 1930 |
|
|
2023
Q3 | $263K | Buy |
1,463
+221
| +18% | +$43.7K | ﹤0.01% | 1754 |
|
|
2023
Q2 | $221K | Sell |
1,242
-299
| -19% | -$68.9K | ﹤0.01% | 1840 |
|
|
2023
Q1 | $332K | Sell |
1,541
-1,092
| -41% | -$262K | ﹤0.01% | 1504 |
|
|
2022
Q4 | $579K | Buy |
2,633
+303
| +13% | +$55.6K | 0.01% | 1318 |
|
|
2022
Q3 | $314K | Buy |
2,330
+37
| +2% | +$6.35K | ﹤0.01% | 1570 |
|
|
2022
Q2 | $371K | Buy |
2,293
+50
| +2% | +$7.81K | ﹤0.01% | 1495 |
|
|
2022
Q1 | $423K | Buy |
2,243
+222
| +11% | +$47.2K | ﹤0.01% | 1386 |
|
|
2021
Q4 | $548K | Sell |
2,021
-84
| -4% | -$28.4K | 0.01% | 1273 |
|
|
2021
Q3 | $764K | Buy |
2,105
+59
| +3% | +$19.3K | 0.01% | 1158 |
|
|
2021
Q2 | $702K | Buy |
2,046
+133
| +7% | +$44.1K | 0.01% | 1109 |
|
|
2021
Q1 | $666K | Buy |
1,913
+689
| +56% | +$228K | 0.01% | 1052 |
|
|
2020
Q4 | $312K | Buy |
1,224
+1,208
| +7,550% | +$333K | ﹤0.01% | 1453 |
|
|
2020
Q3 | $358K | Buy |
+16
| New | +$3.76K | 0.01% | 1025 |
|
Other funds holding ONC
BBA
HA
